Abstract
The conclusion of the Expert Council presents the results of discussing the diagnosis and therapy of interstitial lung diseases in systemic scleroderma. The reason for this discussion was the emergence of new data on the use of nintedanib in this category of patients.
Highlights
В заключении Совета экспертов представлены результаты обсуждения вопросов диагностики и терапии интерстициальных заболеваний легких при системной склеродермии
The conclusion of the Expert Council presents the results of discussing the diagnosis and therapy of interstitial lung diseases in systemic scleroderma
The reason for this discussion was the emergence of new data on the use of nintedanib in this category of patients
Summary
В заключении Совета экспертов представлены результаты обсуждения вопросов диагностики и терапии интерстициальных заболеваний легких при системной склеродермии. «Интерстициальные заболевания легких при системной склеродермии» (14 октября 2019 г., Москва) Резолюция Совета экспертов, посвященного теме «Интерстициальные заболевания легких при системной склеродермии» (14 октября 2019 г., Москва). The resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.